Sponsor Check › Person
Related person on Form D filings · address states as listed: PA, CA, MA, RI, NY, CT, TX · listed Jan 11, 2011 → Aug 14, 2019
Data last updated: Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: not yet · SEC enforcement last checked: not yet
Privacy: business-related public information only. Residential addresses are never shown; only the state from the filing.
The five facts investors ask about first. Each section states what was searched and when. Items still in human review are not shown.
Not yet searched.
Sources to be searched: CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not yet searched. PACER: not searched (RECAP only). · Search queued. Results are added automatically; check back later or follow this page to be notified.
State courts: not yet searched. No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.
SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — not yet searched; State securities regulators searched: AZ (Corporation Commission Securities Division), CA (DFPI — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), DE (DOJ Investor Protection Unit), TX (State Securities Board), WA (DFI) — last crawled Oct 23, 2026, 9:57 PM ET. Other states: not yet searched.
Not yet searched.
Search queued. Results are added automatically; check back later or follow this page to be notified.
Not yet searched.
Sources to be searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not yet searched. PACER: not searched (RECAP only). · Search queued. Results are added automatically; check back later or follow this page to be notified.
State courts: not yet searched. No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.
Comparisons are made for sponsors and sponsor groups, not individual people.
1 of 43 offerings reports sales commissions totalling $1,250,000; 0 report finder's fees; 2 report proceeds to related persons totalling $1,600,000. (includes amounts the issuer reported as estimates)
| Source | Offering (latest filing) | Sales commissions | Finder's fees | To insiders | Paid to sell it |
|---|---|---|---|---|---|
| EDGAR ↗ | Aug 10, 2026 D File 021-593679 | $0 | $0 | $0 The Issuer is obligated to pay a management fee to the General Partner (or an affiliate thereof). | None listed on this filing |
| EDGAR ↗ | Mar 11, 2026 D File 021-576209 | $0 | $0 | $0 The Issuer is obligated to pay a management fee to the General Partner (or an affiliate thereof). | None listed on this filing |
| EDGAR ↗ | Mar 9, 2021 D File 021-391600 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jan 21, 2021 D File 021-386939 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jan 11, 2021 D File 021-385893 | $0 | $0 | $0 The Issuer is obligated to pay a management fee to the General Partner (or an affiliate thereof). | None listed on this filing |
| EDGAR ↗ | Jul 17, 2020 D File 021-371303 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Mar 12, 2020 D File 021-362661 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Dec 3, 2019 D/A File 021-354370 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Aug 14, 2019 D/A File 021-311514 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Apr 22, 2019 D File 021-337812 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Nov 13, 2018 D File 021-325594 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Oct 26, 2018 D File 021-324440 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jul 18, 2018 D File 021-317168 | $0 | $0 | $850,000 (est.) | None listed on this filing |
| EDGAR ↗ | Apr 3, 2018 D File 021-309225 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Nov 15, 2017 D File 021-298743 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Aug 15, 2017 D File 021-292798 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Aug 15, 2017 D File 021-292800 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Apr 20, 2017 D/A File 021-252193 | $1,250,000 (est.) | $0 | $750,000 (est.) | MTS Securities, LLC BrokerCheck CRD 104059 ↗ William Blair & Company BrokerCheck CRD 1252 ↗ |
| EDGAR ↗ | Jul 25, 2016 D File 021-267633 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jun 14, 2016 D File 021-265020 | $0 | $0 | $0 | none no CRD number reported |
| EDGAR ↗ | Apr 4, 2016 D File 021-260605 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jan 22, 2016 D File 021-255761 | $0 | $0 | $0 The Issuer is obligated to pay a management fee to the General Partner (or an affiliate thereof). | None listed on this filing |
| EDGAR ↗ | Nov 5, 2015 D File 021-250787 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jul 20, 2015 D File 021-244021 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | May 4, 2015 D File 021-239073 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Apr 23, 2015 D File 021-238512 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Mar 18, 2015 D File 021-236120 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Mar 13, 2015 D File 021-235865 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Feb 11, 2015 D File 021-233882 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Nov 24, 2014 D File 021-228961 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Aug 29, 2014 D File 021-223855 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | May 23, 2014 D File 021-217968 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Apr 11, 2014 D File 021-215407 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Mar 19, 2014 D/A File 021-180698 | $0 | $0 | $0 The Issuer is obligated to pay a management fee to the General Partner (or an affiliate thereof). | None listed on this filing |
| EDGAR ↗ | Oct 2, 2013 D File 021-203887 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Sep 17, 2013 D File 021-203012 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jul 9, 2013 D File 021-199232 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Apr 12, 2013 D File 021-194949 | $0 | $0 | $0 The Issuer will use proceeds for general working capital purposes which includes payments to its executive officers and other employees in the ordinary course of business. | None listed on this filing |
| EDGAR ↗ | Feb 24, 2012 D File 021-173910 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | May 2, 2011 D/A File 021-153395 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Mar 23, 2011 D File 021-157230 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jun 4, 2010 D File 021-142972 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Nov 25, 2009 D File 021-54609 | $0 | $0 | $0 | None listed on this filing |
As reported by the issuer on Form D (Items 12–15), latest filing per offering (one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.
Counted across every filing this person is listed on (latest filing per offering, per issuer).
| Source | Issuer | Role | Filed | Form | Offering | Sold | Investors | Min. investment |
|---|---|---|---|---|---|---|---|---|
| EDGAR ↗ | Compound Explorer I, L.P. group: Compound | Director Managing Director of the General Partner | Aug 10, 2026 | D | $35,000,000 similar: $155,000–$5,250,000 | $0 | 0 similar: 4–27 | No minimum reported similar: $1,000–$100,000 |
| EDGAR ↗ | Compound 2026, L.P. group: Compound | Director Managing Director of the General Partner | Mar 11, 2026 | D | $115,000,000 similar: $155,000–$5,250,000 | $0 | 0 similar: 4–27 | No minimum reported similar: $1,000–$100,000 |
| EDGAR ↗ | Amunix Pharmaceuticals, Inc. | Director | Mar 9, 2021 | D | $116,999,980 similar: $2,000,000–$19,999,994 | $116,999,980 | 28 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | Amunix Pharmaceuticals, Inc. | Director | Jan 21, 2021 | D | $743,277 similar: $2,000,000–$19,999,994 | $0 | 1 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | Compound 2021, L.P. group: Compound | Director Managing Director of the General Partner | Jan 11, 2021 | D | $55,000,000 similar: $155,000–$5,250,000 | $0 | 0 similar: 4–27 | No minimum reported similar: $1,000–$100,000 |
| EDGAR ↗ | Amunix Pharmaceuticals, Inc. | Director | Jul 17, 2020 | D | $2,579,360 similar: $2,000,000–$19,999,994 | $0 | 3 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | Amunix Pharmaceuticals, Inc. | Director | Mar 12, 2020 | D | $83,590,402 similar: $2,000,000–$19,999,994 | $83,590,402 | 21 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | Molecular Templates, Inc. group: Molecular Templates | Director | Dec 3, 2019 | D/A | $14,999,994 similar: $2,000,000–$19,999,994 | $14,999,994 | 1 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | Molecular Templates, Inc. group: Molecular Templates | Director | Nov 27, 2019 | D | $14,999,994 similar: $2,000,000–$19,999,994 | $14,999,994 | 1 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | RAPID MICRO BIOSYSTEMS, INC. | Director | Aug 14, 2019 | D/A | $60,017,425 similar: $829,831–$9,999,998 | $60,017,425 | 11 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | Poseida Therapeutics, Inc. | Director | Apr 22, 2019 | D | $150,000,000 similar: $2,000,000–$19,999,994 | $142,120,007 | 17 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | COLLEGIUM PHARMACEUTICAL, INC | Director | Nov 13, 2018 | D | $20,000,006 similar: $1,694,259–$16,000,000 | $20,000,006 | 1 similar: 1–13 | No minimum reported similar: $10,000–$55,000 |
| EDGAR ↗ | DataOwl LLC | Director | Oct 26, 2018 | D | $1,000,000 similar: $2,778,046–$25,000,000 | $0 | 0 similar: not enough data | $10,000 similar: $5,000–$10,500 |
| EDGAR ↗ | Velicept Therapeutics, Inc. group: Zoomi | Director | Jul 18, 2018 | D | $15,624,000 similar: $1,694,259–$16,000,000 | $15,508,713 | 16 similar: 1–13 | No minimum reported similar: $10,000–$55,000 |
| EDGAR ↗ | RAPID MICRO BIOSYSTEMS, INC. | Director | May 2, 2018 | D | $60,017,425 similar: $829,831–$9,999,998 | $45,142,425 | 11 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | Poseida Therapeutics, Inc. | Director | Apr 3, 2018 | D | $30,499,990 similar: $2,000,000–$19,999,994 | $30,499,990 | 7 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | Tricida, Inc. | Director | Nov 15, 2017 | D | $57,559,996 similar: $1,694,259–$16,000,000 | $57,559,996 | 13 similar: 1–13 | No minimum reported similar: $10,000–$55,000 |
| EDGAR ↗ | Molecular Templates, Inc. group: Molecular Templates | Director | Aug 15, 2017 | D | $20,000,000 similar: $2,000,000–$19,999,994 | $20,000,000 | 1 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | Molecular Templates, Inc. group: Molecular Templates | Director | Aug 15, 2017 | D | $40,000,000 similar: $2,000,000–$19,999,994 | $40,000,000 | 16 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | Velicept Therapeutics, Inc. group: Zoomi | Director | Apr 20, 2017 | D/A | $26,300,003 similar: $1,694,259–$16,000,000 | $18,410,010 | 25 similar: 1–13 | $4,485 similar: $10,000–$55,000 |
| EDGAR ↗ | Tricida, Inc. | Director | Jul 25, 2016 | D | $55,500,000 similar: $1,694,259–$16,000,000 | $23,908,857 | 6 similar: 1–13 | No minimum reported similar: $10,000–$55,000 |
| EDGAR ↗ | Groop Internet Platform Inc. | Director former director | Jun 14, 2016 | D | $14,999,994 similar: $500,000–$7,000,000 | $14,999,994 | 10 similar: 2–14 | No minimum reported similar: $5,000–$50,000 |
| EDGAR ↗ | Zavante Therapeutics, Inc. | Director | Apr 4, 2016 | D | $45,731,764 similar: $1,694,259–$16,000,000 | $45,731,764 | 54 similar: 1–13 | No minimum reported similar: $10,000–$55,000 |
| EDGAR ↗ | Metamorphic Ventures III, L.P. | Executive Officer Managing Member of the General Partner | Jan 22, 2016 | D | $75,000,000 similar: $155,000–$5,250,000 | $0 | 0 similar: 4–27 | No minimum reported similar: $1,000–$100,000 |
| EDGAR ↗ | Velicept Therapeutics, Inc. group: Zoomi | Director | Dec 1, 2015 | D | $21,050,003 similar: $1,694,259–$16,000,000 | $12,028,576 | 24 similar: 1–13 | $4,485 similar: $10,000–$55,000 |
| EDGAR ↗ | Metamorphic Ventures FD, LLC group: Metamorphic | Executive Officer A Managing Director of the Manager | Nov 5, 2015 | D | $9,985,000 similar: $155,000–$5,250,000 | $9,985,000 | 28 similar: 4–27 | No minimum reported similar: $1,000–$100,000 |
| EDGAR ↗ | Move Loot, Inc. | Director | Jul 20, 2015 | D | $12,318,474 similar: $500,000–$7,000,000 | $9,443,662 | 9 similar: 2–14 | No minimum reported similar: $5,000–$50,000 |
| EDGAR ↗ | RAPID MICRO BIOSYSTEMS, INC. | Director | May 4, 2015 | D | Indefinite similar: $829,831–$9,999,998 | $18,679,991 | 18 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | Voyat Inc. | Director | Apr 23, 2015 | D | $2,000,000 similar: $1,100,015–$10,001,163 | $725,000 | 5 similar: 2–14 | No minimum reported similar: $5,000–$50,000 |
| EDGAR ↗ | RAPID MICRO BIOSYSTEMS, INC. | Director | Mar 18, 2015 | D | Indefinite similar: $829,831–$9,999,998 | $6,000,000 | 6 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | COLLEGIUM PHARMACEUTICAL, INC | Director | Mar 13, 2015 | D | $50,000,000 similar: $1,694,259–$16,000,000 | $50,000,000 | 18 similar: 1–13 | No minimum reported similar: $10,000–$55,000 |
| EDGAR ↗ | Move Loot, Inc. | Director | Feb 11, 2015 | D | $6,265,000 similar: $500,000–$7,000,000 | $5,958,483 | 24 similar: 2–14 | $5,704 similar: $5,000–$50,000 |
| EDGAR ↗ | LaunchKey, Inc. | Director | Nov 24, 2014 | D | $4,072,444 similar: $1,100,015–$10,001,163 | $3,822,442 | 23 similar: 2–14 | No minimum reported similar: $5,000–$50,000 |
| EDGAR ↗ | Civitas Therapeutics, Inc. | Director | Aug 29, 2014 | D | $55,250,000 similar: $2,000,000–$19,999,994 | $55,250,000 | 19 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | Voyat Inc. | Director | May 23, 2014 | D | $2,043,975 similar: $1,100,015–$10,001,163 | $1,843,567 | 19 similar: 2–14 | No minimum reported similar: $5,000–$50,000 |
| EDGAR ↗ | RAPID MICRO BIOSYSTEMS, INC. | Director | Apr 11, 2014 | D | Indefinite similar: $829,831–$9,999,998 | $6,001,413 | 9 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | Metamorphic Ventures II, L.P. group: Metamorphic | Executive Officer A Managing Member of the General Partner | Mar 19, 2014 | D/A | $64,935,000 similar: $155,000–$5,250,000 | $64,935,000 | 131 similar: 4–27 | No minimum reported similar: $1,000–$100,000 |
| EDGAR ↗ | COLLEGIUM PHARMACEUTICAL, INC | Director | Oct 2, 2013 | D | $12,000,000 similar: $1,694,259–$16,000,000 | $4,000,002 | 13 similar: 1–13 | No minimum reported similar: $10,000–$55,000 |
| EDGAR ↗ | Civitas Therapeutics, Inc. | Director | Sep 17, 2013 | D | $38,299,999 similar: $2,000,000–$19,999,994 | $38,299,999 | 11 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | RAPID MICRO BIOSYSTEMS, INC. | Director | Jul 9, 2013 | D | $32,600,000 similar: $829,831–$9,999,998 | $21,733,334 | 10 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | Metamorphic Ventures II, L.P. group: Metamorphic | Executive Officer A Managing Member of the General Partner | Jul 3, 2013 | D/A | $50,000,000 | $29,845,000 | 75 | No minimum reported |
| EDGAR ↗ | Songza, Inc. | Director | Apr 12, 2013 | D | Indefinite | $3,817,923 | 27 | No minimum reported |
| EDGAR ↗ | Metamorphic Ventures II, L.P. group: Metamorphic | Executive Officer A Managing Member of the General Partner | Jul 3, 2012 | D | $50,000,000 | $0 | 0 | No minimum reported |
| EDGAR ↗ | COLLEGIUM PHARMACEUTICAL, INC | Director | Feb 24, 2012 | D | $22,461,190 | $22,461,190 | 12 | No minimum reported |
| EDGAR ↗ | Civitas Therapeutics, Inc. | Director | May 2, 2011 | D/A | $28,600,000 similar: $2,000,000–$19,999,994 | $14,264,706 | 5 similar: 2–16 | $98,250 similar: $10,000–$50,000 |
| EDGAR ↗ | Turiya Media, Inc. | Director | Mar 23, 2011 | D | $1,375,000 | $1,375,000 | 4 | No minimum reported |
| EDGAR ↗ | Civitas Therapeutics, Inc. | Director | Jan 11, 2011 | D | $20,000,000 similar: $2,000,000–$19,999,994 | $10,000,000 | 4 similar: 2–16 | $98,250 similar: $10,000–$50,000 |
| EDGAR ↗ | PRECISION THERAPEUTICS INC | Director | Jun 4, 2010 | D | $35,016,157 similar: $829,831–$9,999,998 | $33,974,532 | 45 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | NCRX OPTICAL SOLUTIONS INC | Director | Nov 25, 2009 | D | $1,000,000 similar: $829,831–$9,999,998 | $800,000 | 4 similar: 2–15 | $1,000 similar: $10,000–$54,310 |
Every row is a Form D or D/A on which the issuer listed this name as a related person. Related-person names are matched on first + last name and the address state on the filing; records that share a name but could not be tied together by a second identifier are listed separately below.
"Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years (7 industry/exemption sets on this page); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.
Not linked to this profile — a second identifier (same issuer, same sponsor group) was not found. Could be the same person or a different one.
People and management entities the issuers listed as related persons on the same Form D filings as David Hirsch. Source: the EDGAR rows in the table above. Showing the 40 with the most shared filings.
None found in sources searched.
Sources searched: SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 · Last checked Oct 23, 2026, 8:41 PM ET.
Export this report as PDF (members · included free during the launch period)
No corrections have been requested for this page.
Free. Logged with status: received → under review → fixed / confirmed with source.
If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.
Members get an email when David Hirsch appears on a new Form D, or when a court case or SEC action is matched to them. See plans →